This inventor holds 5 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: Hummingbird Bioscience Holdings Pte. Ltd., Hummingbird Bioscience Pte. Ltd.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
2 out of 3 Years Active: 2020-2024
Title: Vicente Sancenon: Innovator in Antigen-Binding Molecules
Introduction
Vicente Sancenon is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of five patents, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Among his latest patents are the VISTA antigen-binding molecules and HER3 antigen-binding molecules. The VISTA antigen-binding molecules are disclosed along with nucleic acids and expression vectors encoding them, as well as compositions and methods utilizing these molecules. Similarly, the HER3 antigen-binding molecules are also disclosed, accompanied by nucleic acids, expression vectors, and methods for their application.
Career Highlights
Vicente has worked with notable companies such as Hummingbird Bioscience Holdings Pte. Ltd. and Hummingbird Bioscience Pte. Ltd. His work in these organizations has contributed to the development of cutting-edge biotechnological solutions.
Collaborations
Some of his coworkers include Jerome Douglas Boyd-Kirkup and Piers Ingram, who have collaborated with him on various projects, enhancing the impact of his inventions.
Conclusion
Vicente Sancenon is a distinguished inventor whose work in antigen-binding molecules has the potential to revolutionize therapeutic approaches in medicine. His contributions reflect a commitment to innovation and collaboration in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile